Deborah Gleeson

Dr. Deborah Gleeson is an Associate Professor in the School of Psychology and Public Health at La Trobe University, Australia, and an Associate at La Trobe University’s Centre for Health Law and Society. Deborah holds a Graduate Diploma in Health Promotion, a Master of Public Health and PhD in Health Policy. Her main research focus is the interface between trade and investment agreements and public health, and she has over 35 peer-reviewed publications on this topic, covering a range of topic areas including access to affordable medicines, alcohol and tobacco policy, and food and nutrition. Deborah co-convenes the Political Economy of Health Special Interest Group of the Public Health Association of Australia (PHAA) and frequently represents PHAA on matters related to trade and health. She received a PHAA President’s Award 2015 for public health leadership, engagement and commitment on the impact of international trade issues on public health.

Recent Publications

Tenni, B., Lexchin, J., Sovath, P., Townsend, B., & Gleeson, D. (2025). Protecting Access to Medicines After Cambodia Graduates From Least Developed Country Status: A Policy Analysis. Global Policy. https://doi.org/10.1111/1758-5899.13485

Gleeson, D., Scheibner, J., Tenni, B., Townsend, B., & Nicol, D. (2024). Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap”. International Journal of Health Policy & Management, 13(1), 1-4. DOI: 10.34172/ijhpm.8589.

Van de Wiele, V.L., Kesselheim, A.S., Gleeson, D., Lu, Z., Tu, S.S., & Rome, B.N. (2024). Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA. Pharmaceutical Medicine, 38, 303-310. https://doi.org/10.1007/s40290-024-00527-w

Tenni, B., Lexchin, J., Akaleephan, C., Kittitrakul, C., Townsend, B., & Gleeson, D. (2024). Factors Influencing the Prioritisation of Access to Medicines in Trade-related Intellectual Property Policymaking in Thailand. The Journal of World Intellectual Property, 27(3), 532-562. https://doi.org/10.1111/jwip.12316

Tenni, B., Lexchin, J., Akaleephan, C., Kittitrakul C., & Gleeson, D. (2024). The potential impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s hepatitis C treatment program. Globalization and Health, 20, 46. https://doi.org/10.1186/s12992-024-01053-9

Tenni, B., Lexchin, J., Phin, S., & Gleeson, D. (2024) Cambodia’s Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia? International Journal of Social Determinants of Health and Health Services, 54(3), 197-322. https://doi.org/10.1177/27551938241242602